Performance of immunochemical faecal occult blood test in colorectal cancer screening in average-risk population according to positivity threshold and number of samples

International Journal of Cancer

Volumn 125, Issue 5, 2009, Pages 1127-1133

  Guittet, Lydia ^a   Bouvier, Véronique ^a,b   Mariotte, Nicole ^c   Vallee, Jean Pierre ^b   Levillain, Romuald ^c   Tichet, Jean ^c   Launoy, Guy ^a  

^a INSERM   (France)

^b Association Mathilde   (France)

^c IRSA Institut Inter Régional Pour la Santé   (France)

Author keywords

Colonoscopy; Colorectal neoplasms; Mass screening; Occult blood; Sensitivity and specificity

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SCREENING; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; FEMALE; GUAIAC FECAL OCCULT BLOOD TEST; HUMAN; IMMUNOCHEMICAL FECAL OCCULT BLOOD TEST; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADENOMA; AGED; COLONIC POLYPS; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FEMALE; HEMATOLOGIC TESTS; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; NEOPLASM STAGING; OCCULT BLOOD; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 67650032410     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24407     Document Type: Article

References (25)

1. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am. J Gastroenterol 2008; 103:1541-9.
2. Allison JE, Tekawa IS, Ransom IJ, Adrain AL. A comparison of fecal occult blood tests for colorectal cancer screening. N Engl J Med 1996;334:155-9.
3. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AV, Bouvier VM, Caces ER. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer 2005;115:493-6.
4. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Shiratori Y. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8.
5. Guittet L, Bouvier V, Mariotte N, Vallee JP, Arsène D, Boutreux S, Tichet J, Launoy G. Comparison of a guaiac based and an immunochemical faecal occult blood test in screening for colorectal cancer in a general average-risk population. Gut 2007;56:210-4.
6. Castiglione G, Visioli CB, Ciatto S, Grazzini G, Bonanomi AG, Rubeca T, Mantellini P, Zappa M. Sensitivity of latex agglutination faecal occult blood test in the Florence District population-based colorectal cancer screening programme. Br J Cancer 2007;96: 1750-4.
7. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, et al. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst 2007;99:1462-70.
8. Van Rossum LG, van Rijn AF, Laheij RJ, van Oijen MG, Fockens P, van Krieken HH, Verbeek AL, Jansen JB, Dekker E. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008;135:82-90.
9. Fletcher RH. Commentary. ACP J Club 1996;124:74.
10. Allison JE. Colon cancer screening guidelines 2005: the fecal occult blood test option has become a better FIT. Gastroenterology 2005;129:745-8.
11. Imperiale TF. Quantitative immunochemical fecal occult blood tests: is it time to go back to the future? Ann Intern Med 2007;146: 309-11.
12. Mandel JS. Which colorectal cancer screening test is best? J Natl Cancer Inst 2007;99:1424-5.
13. Ransohoff DF. What is the role of iFOBT in screening for colorectal cancer? Gut 2007;56:1343-4.
14. Castiglione G, Grazzini G, Miccinesi G, Rubeca T, Sani C, Turco P, Zappa M. Basic variables at different positivity thresholds of a quantitative immunochemical test for faecal occult blood. J Med Screen 2002;9:99-103.
15. Edwards JB. Screening for colorectal cancer using faecal blood testing: varying the positive cut-off value. Pathology 2005;37: 565-8.
16. Levi Z, Rozen P, Hazazi R, Vilkin A, Waked A, Niv Y. A quantitative immunochemical fecal occult blood test for colorectal neoplasia. Ann Int Med 2007;146:244-55.
17. Ciatto S, Martinelli F, Castiglione G, Mantellini P, Rubeca T, Grazzini G, Bonanomi AG, Confortini M, Zappa M. Association of FOBT-assessed faecal Hb content with colonic lesions detected in the Florence screening programme. Br J Cancer 2007;96:218-21.
18. Schatzkin A, Connor RJ, Taylor PR, Bunnag B. Comparing new and old screening tests when a reference procedure cannot be performed on all screenees. Example of automated cytometry for early detection of cervical cancer. Am J Epidemiol 1987;125:672-8.
19. Cheng H, Macaluso M. Comparison of the accuracy of two tests with a confirmatory procedure limited to positive results. Epidemiology 1997;8:104-6.
20. Chock C, Irwig L, Berry G, Glasziou P. Comparing dichotomous screening tests when individuals negative on both tests are not verified. J Clin Epidemiol 1997;50:1211-7.
21. Guittet L, Launoy G. Diagnostic accuracy of immunochemical faecal occult blood tests according to number of samples and positivity threshold. J Med Screen 2008;15:48-9.
22. Cole SR, Young GP, Esterman A, Cadd B, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen 2003;10:117-22.
23. Berchi C, Bouvier V, Réaud JM, Launoy G. Cost-effectiveness analysis of two strategies for mass screening for colorectal cancer in France. Health Econ 2004;13:227-38.
24. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
25. Zhang DD, Zhou XH, Freeman DH, Freeman JL. A non-parametric method for the comparison of partial areas under ROC curves and its application to large health care data sets. Stat Med 2002;21: 701-15.